Faculty Presentations

Thursday, Nov. 16

Education Day – Neurofibromatosis
Models of Neurofibromatosis 1 Disease and Insights into the Biology of the Disease
3:55-4:15 p.m. | Exhibit Hall C
Speaker: Corina Anastasaki, PhD (X/Twitter: @Corina_Anast)
*This session will have CME.

Friday, Nov. 17

Concurrent Session: Single Cell Biology
Tumor Formation, Progression and Treatment Response
7:15-8:45 a.m. | Ballroom A
CO-CHAIR and INTRODUCER: Albert H. Kim, MD, PhD (X: @AlbertHKimMDPhD)
*This session will have CME.

Abstract Concurrent Session: Health Disparities
DISP-14 – The association between Medicaid enrollment continuity and childhood, adolescent, and young adult brain tumor survival
11:05-11:15 a.m. | Room 121-122
PRESENTER: Kimberly J. Johnson, PhD, MPH (X: @KimJohnson_PhD)
*This session will have CME.

Concurrent Session: Pediatric CNS Tumors and Cancer Predisposition
Neurodevelopmental, Genetic and Environmental Determinants of CNS Tumor Formation in NF1
11:50 a.m.-12:10 p.m. | Ballroom B
PRESENTER: Nicole M. Brossier, MD, PhD

Plenary II
CNSC-43 – Targeting neuronal excitability for Nf1 low-grade glioma therapy
2:30-2:40 p.m. | Exhibit Hall C
PRESENTER: Corina Anastasaki, PhD (X: @Corina_Anast)
*Award winner


7:30 – 9:30 p.m. | Exhibit Hall A/B

IMMU-28 – TREM2 inhibition reprograms myeloid cells to stimulate anti-tumor immunity through both direct and indirect mechanisms
PRESENTER: Albert H. Kim, MD, PhD (X: @AlbertHKimMDPhD)

RADT-01 – Baseline Hippocampal volume as a predictor of neurocognitive changes after WBRT or HA-WBRT: Secondary Analysis of NRG Oncology CC001
PRESENTER: Christopher Abraham, MD

Saturday, Nov. 18

Abstract Concurrent Session: Molecular Pathology – Diagnosis
EPCO-53 – Multi-scale regulation of signaling cascades and tumor evolution in high grade astrocytomas
11:55 a.m.-12 p.m. | Room 118-120
PRESENTER: Milan G. Chheda, MD

Abstract Concurrent Session: Rare Tumors
3:45-5:15 p.m. | Room 121-122
CO-MODERATOR: Albert H. Kim, MD, PhD (X: @AlbertHKimMDPhD)

Sunday, Nov. 19

Session: Abstract Concurrent Session: Pediatrics II

MODL-17 – Obesogenic diet increases NF1-optic pathway glioma formation through effects on the tumor cell of origin
10:45-10:55 a.m. | Room 121-122
PRESENTER: Nicole M. Brossier, MD, PhD

Session: Abstract Concurrent Session: Pediatrics II
CTNI-69 – Real-time drug screening and genomic testing to determine individualized treatment plans in children and young adults with relapsed medulloblastoma: preliminary report of PNOC027
11:35-11:40 a.m. | Room 121-122
PRESENTER: Margaret Shatara, MD